Opendata, web and dolomites

SmartHeart SIGNED

SmartHeart, a 3D in vitro assay for improved assessment of cardiac drug efficacy and toxicity

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SmartHeart project word cloud

Explore the words cloud of the SmartHeart project. It provides you a very rough idea of what is the project "SmartHeart" about.

3d    structure    feedback    culture    drugs    academic    diseases    trials    competences    retrieve    cultured    meet    commercialized    leader    techniques    contractility    maturation    fine    compatible    limiting    quantitative    tune    closer    screening    hcs    outs    hts    standards    animal    action    clinical    drug    assays    cardiomyocytes    final    vitro    device    cells    human    stem    ultimate    pluripotent    proprietary    transients    stage    nature    currently    smartheart    cms    predict    microstructured    act       calcium    cardiac    sub    expertise    commercial    angle    simultaneously    models    physics    entering    qualitative    put    4dcell    er    3dcell    shortcomings    technological    pharma    candidate    assay    specifications    whom    cros    managerial    acquired    body    gel    ethical    platforms    cellular    answer    mimic    industrial    imaging    maturity    efficient    minimized    career    observation    multiwell    read    resolution    plates   

Project "SmartHeart" data sheet

The following table provides information about the project.

Coordinator
4DCELL 

Organization address
address: 14 RUE DE LA BEAUNE BAT C ETAGE 2
city: MONTREUIL
postcode: 93100
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Total cost 196˙707 €
 EC max contribution 196˙707 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2019
 Funding Scheme MSCA-IF-EF-SE
 Starting year 2020
 Duration (year-month-day) from 2020-03-02   to  2022-03-01

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    4DCELL FR (MONTREUIL) coordinator 196˙707.00

Map

 Project objective

Currently, animal models are still widely used in the pre-clinical stage of drug development to mimic human diseases or predict the human body’s response to candidate drugs. However, their use should be minimized as much as possible due to ethical issues and since only 9.6% of drugs entering phase I of clinical trials end up being commercialized. Therefore, the goal of this action is to develop a novel proprietary 3D in vitro cardiac assay. The SmartHeart will retrieve several of the most important read-outs commonly assessed to study the impact of drugs at the cardiac level in the pre-clinical phase. The all in one assay will be based on a microstructured gel where cardiac cells, as cardiomyocytes derived from induced pluripotent stem cells will be cultured. The SmartHeart will answer to the shortcomings of academic and commercial available in vitro assays, by enabling the qualitative and quantitative measurement of several parameters, as contractility and Calcium transients. Simultaneously, the assay will enable sub-cellular structure observation via high-resolution imaging techniques. Furthermore, the 3D nature of the assay will contribute to the efficient maturation of the induced CMs, which is still a limiting factor when not using cardiac human cells, but rather induced CMs, in in vitro assays. The ultimate aim of the project is to make this device available to screening platforms, e.g. Pharma or CROs. The technology will be implemented in multiwell plates compatible with the standards of HTS/HCS and will be available to early-users, from whom feedback will be acquired, enabling to fine tune the specifications of the final device. This project will meet the best of the ER competences in physics, with the expertise of 4Dcell in 3Dcell culture systems. With this project, the ER will reach a level of maturity on several technological, managerial and industrial aspects providing her a new career angle and put her a step closer to act as a leader in research.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SMARTHEART" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SMARTHEART" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

ReproMech (2019)

The Molecular Mechanisms of Cell Fate Reprogramming in Vertebrate Eggs

Read More  

EngPTC2 (2019)

Exploring new technologies for the next generation pulse tube cryocooler below 2K

Read More  

BB-SLM (2020)

Polychromatic digital optics for structured light

Read More